References
- Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 2001;1:251–261
- Mitscher LA, Pillai SP, Gentry EJ, Shankel DM. Multiple drug resistance. Med Res Rev 1999;19(6):477–496
- Berber I, Cokmus C, Atalan E. Characterization of Staphylococcus species by SDS-PAGE of whole-cell and extracellular proteins. Microbiology 2003;72:54–59
- Jeewoo L, Jiyoun L, Jiyoung K, Soo Y K. N-(3-acyloxy-2-benzylpropyl)-N9-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics. Bioorgan Med Chem Lett 2001; 9(1):19–32
- Schoeder MC, Showalter HD. Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure-Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity. J Med Chem 2001; 44:1915–1926
- Venkatachalam TK, Qazi S, Samuel P, Uckun FM. Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents inhibiting IgE/Fci RI receptor mediated mast cell leukotriene release. Bioorgan Med Chem 2003;11(6):1095–1105
- Tilley JW. Levitan P, Kramer MJ. Adamantylthiourea derivatives as antiviral agents. J Med Chem 1979;22(8):1009–1010
- Siddique B, Pandeya SN, Khan SA, Stables JS. Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain. Bioorgan Med Chem Lett. 2007;17:255–259
- Bell FW, Cantrell AS, Hogberg M. Phenethylthiazolethiourea (PEW) Compounds, a New Class of HIV- 1 Reverse Transcriptase Inhibitors. 1. Synthesis and Basic Structure-Activity Relationship Studies of PEW Analogues. J Med Chem 1995;38:4929–4936
- Young GS, Kyung HM, Jin KK. Novel Potent Antagonists of Transient Receptor Potential Channel Vanilloid Subfamily Member 1: Structure- Activity Relationship of 1,3-Diarylalkyl Thiourea Possessing New Vanilloid Equivalents. J Med Chem., 2005;48:5823–5836
- Cappola GM, Damon RE, Paterniti JR. Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents. Bioorgan Med Chem Lett. 2006:16:113–117
- Cappola GM, Damon RE, Paterniti JR. Thiourea-Based Gemfibrozil Analogues as HDL-Elevating Agents. Bioorgan Med Chem Lett. 2002;12:2439–2442
- Esteves-Souza A, Pissinate K, Nascimento Md-G, Grynberg NF. Synthesis, cytotoxicity, and DNA-topoisomerase inhibitory activity of new asymmetric ureas and thioureas. Bioorgan Med Chem. 2006;14(2):492–499
- loev B, Bender PE, Bowman H. Amidines. 31.Thiourea possessing antihypertensive activity. J Med Chem 1972;15:1024–1025
- Phetsuksiri B, Baulard AR, Cooper AM, Minnikin DE, Douglas JD, Besra GS. J. Antimycobacterial Activities of Isoxyl and New Derivatives through the Inhibition of Mycolic Acid Synthesis. Antimicrob. Agents Chemother 1999;43:1042–1051
- Seth P, Ranken R, Robinson DE, Osgood SA, Risen LM. Aryl urea analogs with broad–spectrum antibacterial activity. Bioorgan Med Chem 2004;14(22):5569–5572
- Clause GW, Understanding Microbes: A Laboratory Textbook for Microbiology, W.H. Freeman and Company, New York, USA, 1989
- Herr RJ, Kuhler JL, Meckler H, Opalka CJ. A Convenient Method for the Preparation of Primary and Symmetrical N,N’–Disubstituted Thiourea. Synthesis 2000;11:1569–1574